Disease Markers

/ Table of Contents: 2019

Table of Contents

Table of Contents: 2019

Disease Markers -
Special Issue
- Volume 2019
- Article ID 2568069
- Research Article

Links between High-Sensitivity C-Reactive Protein and Pulse Wave Analysis in Middle-Aged Patients with Hypertension and High Normal Blood Pressure

Ioana Mozos | Daniela Jianu | ... | Dana Stoian

Disease Markers -
Special Issue
Volume 2019
- Article ID 6270187
- Research Article

Maternal Serum Angiogenic Factor sFlt-1 to PlGF Ratio in Preeclampsia: A Useful Marker for Differential Diagnosis and Prognosis Evaluation in Chinese Women

Wei-zhen Lou | Fang Jiang | ... | Jin-song Gao

Disease Markers -
Special Issue
- Volume 2019
- Article ID 7838195
- Review Article

Gas6/TAM Receptors in Systemic Lupus Erythematosus

Philip L. Cohen | Wen-Hai Shao

Disease Markers -
Special Issue
Volume 2019
- Article ID 7165257
- Research Article

Selected Blood Inflammatory and Metabolic Parameters Predicted Successive Bilateral Sudden Sensorineural Hearing Loss

Xueyuan Zhang | Yinlun Weng | ... | Yongkang Ou

Disease Markers -
Special Issue
- Volume 2019
- Article ID 5462562
- Editorial

Developmental Gene Markers in Tumor Pathogenesis and Progression

Monica Cantile | Giuseppe Palmieri | Gerardo Botti

Disease Markers -
Special Issue
Volume 2019
- Article ID 6131548
- Research Article

PCDHGB7 Increases Chemosensitivity to Carboplatin by Inhibiting HSPA9 via Inducing Apoptosis in Breast Cancer

Siqi Hou | Ming Shan | ... | Lei Zhang

Disease Markers -
Special Issue
- Volume 2019
- Article ID 7816438
- Research Article

Expression of B2 Receptor on Circulating CD34-Positive Cells and Outcomes of Myocardial Infarction

Cong Fu | Yuhan Cao | ... | Yang Ling

Disease Markers -
Special Issue
Volume 2019
- Article ID 4391957
- Letter to the Editor

Response to: Comment on “Sex Differences in the Association between Night Shift Work and the Risk of Cancers: A Meta-Analysis of 57 Articles”

Wen Liu | Zhonghan Zhou | ... | Guiming Zhang

Disease Markers -
Special Issue
Volume 2019
- Article ID 2364943
- Research Article

Characterization of T-Cell Receptor Repertoire in Patients with Rheumatoid Arthritis Receiving Biologic Therapies

Che-Mai Chang | Yu-Wen Hsu | ... | Wei-Chiao Chang

Disease Markers -
Special Issue
Volume 2019
- Article ID 4824902
- Research Article

KIF5A Promotes Bladder Cancer Proliferation In Vitro and In Vivo

Da-Wei Tian | Zhou-Liang Wu | ... | Hai-Long Hu

Disease Markers -
Special Issue
Volume 2019
- Article ID 9802839
- Research Article

Serum Levels of Joining Chain-Containing IgA1 Are Not Elevated in Patients with IgA Nephropathy

Guanhong Li | Xiaoyan Wang | ... | Ruitong Gao

Disease Markers -
Special Issue
Volume 2019
- Article ID 2513026
- Research Article

Prognostic Value of the Advanced Lung Cancer Inflammation Index in Patients with Lung Cancer: A Meta-Analysis

Yi Zhang | Bo Chen

Disease Markers -
Special Issue
Volume 2019
- Article ID 5769514
- Research Article

Polymorphisms -455G/A and -148C/T and Fibrinogen Plasmatic Level as Risk Markers of Coronary Disease and Major Adverse Cardiovascular Events

Luis Miguel Canseco-Avila | Alexander Lopez-Roblero | ... | Rocio Ortiz-Lopez

Disease Markers -
Special Issue
Volume 2019
- Article ID 9698367
- Research Article

Assessment of the Concentration of Bone Metabolism Markers: Sclerostin and FGF-23 in Children with Idiopathic Nephrotic Syndrome Treated with Glucocorticosteroids

Agnieszka Pukajło-Marczyk | Anna Jakubowska | ... | Danuta Zwolińska

Disease Markers -
Special Issue
Volume 2019
- Article ID 9140789
- Research Article

Long-Chain Fatty Acids and Inflammatory Markers Coaccumulate in the Skeletal Muscle of Sarcopenic Old Rats

Thea Laurentius | Robert Kob | ... | Leo Cornelius Bollheimer

8|9|10|11|12|13|14|15

Evaluate your manuscript with the free Manuscript Language Checker

Author guidelines

Editorial board

Databases and indexing

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.